Related Experiment Video

Updated: Aug 8, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells

Alessia Montagnoli1, Pierluigi Tenca, Francesco Sola

  • 1Department of Biology, Nerviano Medical Science, Nerviano, Italy.

Cancer Research
|October 7, 2004
PubMed

Insights

Inhibiting Cdc7 kinase halts cancer cell S phase, causing cell death. Normal cells utilize p53 to prevent lethal S phase progression when Cdc7 is low, highlighting a novel DNA synthesis regulation mechanism.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Cdc7 kinase is crucial for regulating S phase by activating DNA replication origins.
  • Tumor cells lacking Cdc7 undergo abortive S phase, leading to cell death.
  • Normal cells exhibit different responses to Cdc7 depletion compared to tumor cells.

Purpose of the Study:

  • To investigate the role of Cdc7 kinase in regulating DNA synthesis and cell cycle progression.
  • To characterize the p53-dependent pathway that prevents lethal S phase in normal fibroblasts lacking Cdc7.
  • To explore the potential of Cdc7 kinase inhibition as an anticancer strategy.

Main Methods:

  • Small interfering RNA (siRNA) was used to down-regulate Cdc7 expression in tumor cell lines and normal fibroblasts.
  • Cell cycle progression and viability were assessed in Cdc7-depleted cells.
  • The role of p53 in maintaining the checkpoint and cell viability was examined.

Main Results:

  • Cdc7 depletion in tumor cells resulted in abortive S phase and cell death via apoptosis or aberrant mitosis.
  • Cdc7-depleted tumor cells did not trigger a robust checkpoint response.
  • In normal fibroblasts, a p53-dependent pathway prevented lethal S phase progression and was required for cell viability.
  • p53 is essential for maintaining the checkpoint and cell viability in the absence of sufficient Cdc7 kinase.

Conclusions:

  • A novel mechanism regulating DNA synthesis in human cells involving Cdc7 and p53 has been identified.
  • Cdc7 kinase plays a critical role in ensuring proper S phase progression.
  • Inhibition of Cdc7 kinase is a promising therapeutic strategy for developing new anticancer agents.

More Related Videos

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...